Progyny (NASDAQ: PGNY) reported Q3 EPS of $0.45, $0.32 better than the analyst estimate of $0.13. Revenue for the quarter came in at $313.35 million versus the consensus estimate of $299.23 million.

GUIDANCE:

Progyny sees FY2025 EPS of $1.79-$1.82, versus the consensus of $1.82. Progyny sees FY2025 revenue of $1.26-1.28 billion, versus the consensus of $1.26 billion.

Progyny sees Q4 2025 EPS of $0.37-$0.40, versus the consensus of $0.39. Progyny sees Q4 2025 revenue of $292.7-307.7 million, versus the consensus of $302.9 million.

For earnings history and earnings-related data on Progyny (PGNY) click here.